Answers are grounded in this paper and cite their sources.
Overweight could be considered a tumorigenic immune-dysfunction that could be effectively reversed by ICIs. BMI could be a useful predictive tool in clinical practice and a stratification factor in prospective clinical trials with ICIs.
No takes yet. Share an insight, caveat, or question.
Cortellini et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: